Tag:
Medicis Pharmaceutical
Latest Headlines
Latest Headlines
Is the time right for Valeant to snap up Medicis?
While announcing second-quarter earnings yesterday, Medicis Pharmaceuticals CEO Jonah Shacknai said he plans to get back to his normal schedule soon following a series of personal tragedies that kept
Medicis inks $58M dermatology pact with India's Lupin
The media blitz focused on Medicis CEO Jonah Shacknai in the wake of the bizarre death of his girlfriend hasn't prevented the company from completing new development pacts. While a U.S. subsidiary of
Medicis CEO's son dies after last week's accident
The 6-year-old son of Medicis Pharmaceutical founder and CEO Jonah Shacknai has died from injuries suffered in an accident at his California home last week, the family announced. The accident took
Medicis shares drop on death at CEO's house
When do a CEO's personal problems become worrisome to investors? Well, it depends on the problem. In the case of Medicis Pharmaceutical chief Jonah Shacknai, the answer is, "Almost immediately." Two
Anacor inks $160M acne drug pact with Medicis
Anacor Pharmaceuticals will pocket $7 million and gain the potential to garner up to $153 million more under its pact to work with Medicis Pharmaceutical on boron-based small molecule therapies for
Senate nips Botax from healthcare reform
So, who's more powerful in Washington: Tanning-bed companies or cosmetic-drug makers? The latter, of course--and the proof is in the pudding otherwise known as healthcare reform. The latest Senate
Allergan, Medicis lobby hard against 'Botax'
While the pharma industry in general is lobbying hard for its cause vis-a-vis healthcare reform, makers of cosmeceuticals are battling on two fronts. The Senate's reform bill includes a 5 percent
Medicis, Allergan fight for wrinkle-fighting consumers
Cosmetic drugs are hot and happening even as the economy limps along--just take a gander at cosmeceuticals specialist Medici's latest numbers as proof. But not all beautifying treatments are created
Botox rivals could fuel big DTC fight
Watch out, Botox. A couple of competitors could soon be breathing down your wrinkle-free neck. France's Ipsen has won U.K. approval to sell its muscle relaxant Azzalure for use against brow
Cosmetic pharma remains steady in downturn
Despite the U.S. economic crisis, men and women are still turning to pharma to stay pretty, according to the Wall Street Journal. About 75 percent of plastic surgeons responding to a American Society
